Ursprung des Netzwerks ersten Grades von Josh Xu
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
11
| Public Company | Biotechnology | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Josh Xu
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Investment Managers | Chief Investment Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| New York University | College/University | Masters Business Admin Graduate Degree | |
| KADMON HOLDINGS, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Founder Founder | |
| ARYA SCIENCES ACQUISITION CORP IV | Financial Conglomerates | Founder Founder | |
Shanghai Lianbio Development Co., Ltd.
 Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of LianBio, Shanghai Lianbio Development Co., Ltd. is a company that manufactures paradigm-shifting medicines to patients. The company is based in Shanghai, China. The CEO of the Chinese company is Debra Yu. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Prolaio, Inc.
 Prolaio, Inc. BiotechnologyHealth Technology Prolaio, Inc. is a company founded in 2021 that engages in research and development of medical. The company is based in Scottsdale, AZ. | Biotechnology | President Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree | |
| CELLULAR BIOMEDICINE GROUP, INC. | Biotechnology | Corporate Officer/Principal | |
| University of London | College/University | Undergraduate Degree | |
| University of Cambridge | College/University | Graduate Degree | |
GlaxoSmithkline Ltd.
 GlaxoSmithkline Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Ltd. is a company based in Hong Kong, Hong Kong. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018. | Pharmaceuticals: Major | President | |
| BridgeBio Chemistry, Inc. | President | ||
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Phoenix Tissue Repair, Inc.
 Phoenix Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Phoenix Tissue Repair, Inc. develops biopharmaceuticals. The company is based in Boston, MA. | Pharmaceuticals: Major | President | |
| Calcilytix Therapeutics, Inc. | President | ||
| Adrenas Therapeutics, Inc. | Treasurer | ||
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017. | Pharmaceuticals: Major | President | |
| BridgeBio Services, Inc. | Chief Executive Officer | ||
| University of Massachusetts | College/University | Undergraduate Degree | |
| HILLEVAX, INC. | Biotechnology | Director/Board Member | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Founder | |
| Tufts University | College/University | Undergraduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Medical Specialties | Corporate Officer/Principal | |
Council of the Americas, Inc.
 Council of the Americas, Inc. Miscellaneous Commercial ServicesCommercial Services Council of the Americas, Inc. is a non-profit organization, which engages in the management of professional membership organization. It aims to promote economic and social development, open markets, rule of law, and democracy. The firm is composed of companies representing the sectors of banking and finance, consulting services, consumer products, energy and mining, manufacturing, media, technology, and transportation. The company was founded by David Rockefeller Sr. in 1965 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member | |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| Meet The Writers, Inc. | Director/Board Member | ||
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Shanghai Jiao Tong University | College/University | Undergraduate Degree | |
| Fudan University | College/University | Doctorate Degree | |
| CSPC PHARMACEUTICAL GROUP LTD. | Biotechnology | Corporate Officer/Principal | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Rotman School of Management | College/University | Masters Business Admin | |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree | |
| HBM HOLDINGS LIMITED | Pharmaceuticals: Other | Director/Board Member | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
Perceptive Advisors LLC
 Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Investment Managers | Chief Investment Officer | |
Xontogeny LLC
 Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 39 |
| China | 7 |
| Vereinigtes Königreich | 3 |
| Hong Kong | 2 |
| Irland | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 12 |
| Finance | 8 |
| Commercial Services | 4 |
Operativ
| Director/Board Member | 38 |
| Corporate Officer/Principal | 28 |
| Chief Executive Officer | 13 |
| Founder | 12 |
| Undergraduate Degree | 10 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Adam Stone | 18 |
| Neil Kumar | 18 |
| Konstantin Poukalov | 15 |
| Tassos Gianakakos | 10 |
| Susan Silbermann | 10 |
| Wei Wei Chen | 7 |
| Michael Humphries | 6 |
| Brianne Jahn | 5 |
| Pascal Qian | 5 |
| Ehong Gu | 4 |
| Levvy Lv | 3 |
